These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22202376)

  • 1. [Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer].
    Hamakawa T; Kurokawa Y; Takiguchi S; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Mori M; Dok Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2342-4. PubMed ID: 22202376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
    Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
    Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced gastric cancer showing pathological CR after neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 combination].
    Usuda A; Nashimoto A; Yabusaki H; Nakagawa S; Matsuki A; Tsuchiya Y; Takii Y; Nomura T; Maruyama S; Homma K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1687-90. PubMed ID: 21996968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1].
    Mihara K; Egawa T; Kemmochi T; Irino T; Okamura A; Inaba Y; Eto E; Segami K; Ito Y; Hayashi S; Nagashima A
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2357-9. PubMed ID: 22202381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.
    Hirakawa M; Sato Y; Ohnuma H; Takayama T; Sagawa T; Nobuoka T; Harada K; Miyamoto H; Sato Y; Takahashi Y; Katsuki S; Hirayama M; Takahashi M; Ono M; Maeda M; Takada K; Hayashi T; Sato T; Miyanishi K; Takimoto R; Kobune M; Hirata K; Kato J
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):789-97. PubMed ID: 23338051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002.
    Ito S; Sano T; Mizusawa J; Takahari D; Katayama H; Katai H; Kawashima Y; Kinoshita T; Terashima M; Nashimoto A; Nakamori M; Onaya H; Sasako M
    Gastric Cancer; 2017 Mar; 20(2):322-331. PubMed ID: 27299887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer.
    Kurokawa Y; Hamakawa T; Miyazaki Y; Takahashi T; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Anticancer Res; 2015 Apr; 35(4):2223-8. PubMed ID: 25862882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer.
    Aoyama T; Nishikawa K; Fujitani K; Tanabe K; Ito S; Matsui T; Miki A; Nemoto H; Sakamaki K; Fukunaga T; Kimura Y; Hirabayashi N; Yoshikawa T
    Ann Oncol; 2017 Aug; 28(8):1876-1881. PubMed ID: 28486692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.
    Migita K; Nashimoto A; Yabusaki H; Matsuki A; Aizawa M
    Int J Clin Oncol; 2016 Feb; 21(1):102-9. PubMed ID: 26017926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer.
    Tsuchida K; Sato T; Aoyama T; Atsumi Y; Kano K; Maezawa Y; Kazama K; Numata M; Yamada T; Tamagawa H; Murakami H; Oshima T; Saeki H; Cho H; Yukawa N; Yamamoto Y; Masuda M; Rino Y
    Jpn J Clin Oncol; 2021 Mar; 51(3):371-378. PubMed ID: 33283236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
    Hayata K; Ojima T; Nakamori M; Nakamura M; Katsuda M; Kitadani J; Takeuchi A; Tabata H; Maruoka S; Yamaue H
    Anticancer Res; 2018 Sep; 38(9):5267-5273. PubMed ID: 30194177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of S-1 plus docetaxel combination therapy for patients with advanced gastric cancer].
    Nishiwaki H; Yamada T; Tachi K; Iwasaki H; Hori Y; Umemura S; Yamakawa Y; Kurimoto T; Ban T; Fujiwara K; Hayashi K; Nemoto A; Shiroko J; Orito E
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1663-6. PubMed ID: 19838024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of patients with advanced gastric cancer undergoing S-1/CDDP combined neoadjuvant chemotherapy].
    Kikuchi D; Ishii Y; Saitou M; Yamada M; Takenoshita S
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1113-7. PubMed ID: 21772093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer.
    Sasaki K; Onodera S; Otsuka K; Satomura H; Kurayama E; Kubo T; Takahashi M; Ito J; Nakajima M; Yamaguchi S; Miyachi K; Kato H
    Med Oncol; 2017 Aug; 34(8):139. PubMed ID: 28707042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced gastric cancer responding to neoadjuvant chemotherapy with S-1 and CDDP combination].
    Terakura M; Ikebe T; Nishioka T; Horiike M; Kaneko M
    Gan To Kagaku Ryoho; 2010 May; 37(5):887-9. PubMed ID: 20495321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination].
    Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamazaki M; Nishida T; Doki Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):1996-8. PubMed ID: 19106502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1, followed by gastrectomy with D2 lymph node dissection for high-risk advanced gastric cancer: results of the KDOG1001 trial.
    Hosoda K; Azuma M; Katada C; Moriya H; Mieno H; Ishido K; Ema A; Ushiku H; Wada T; Washio M; Watanabe A; Higuchi K; Tanabe S; Koizumi W; Watanabe M; Yamashita K
    Gastric Cancer; 2019 May; 22(3):598-606. PubMed ID: 30284080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
    Sugishita H; Ishida N; Yoshida M; Sato K; Doi T; Horiuchi A; Watanabe Y
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1385-8. PubMed ID: 20647733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study.
    Kunisaki C; Ono HA; Hasegawa S; Oshima T; Fujii S; Tokuhisa M; Izumisawa Y; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I
    J Chemother; 2012 Dec; 24(6):364-8. PubMed ID: 23174102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].
    Yasui T; Mukubo H; Sato N; Kita I; Fushida S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2229-31. PubMed ID: 24394068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.